Beijing Tongrentang Co., Ltd (SHA: 600085)

Market Cap	58.34B
Revenue (ttm)	17.96B
Net Income (ttm)	1.63B
Shares Out	1.37B
EPS (ttm)	1.19
PE Ratio	35.84
Forward PE	41.30
Dividend	0.50 (1.16%)
Ex-Dividend Date	Oct 10, 2024

Volume	17,396,739
Open	42.87
Previous Close	42.94
Day's Range	42.29 - 44.26
52-Week Range	30.84 - 55.74
Beta	0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2024

About Beijing Tongrentang

Beijing Tongrentang Co., Ltd engages in the scientific research, production, distribution, and sale of Chinese medicines in China and internationally. The company provides product formulations, such as pills, powders, liquors, capsules, oral liquids, and dripping pills in the areas of cardiovascular, gynecology, heat clearing class, respiratory system, tonic and soothe the nerves, digestive system, pediatrics, expelling wind and dampness, orthopedics, five senses, skin surgery, spiritual, and food alcohol diseases. It sells its products under t...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 16,777
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600085

Financial Performance

In 2023, Beijing Tongrentang's revenue was 17.86 billion, an increase of 16.19% compared to the previous year's 15.37 billion. Earnings were 1.67 billion, an increase of 16.92%.